Deutsche Bank raised the firm’s price target on Option Care Health (OPCH) to $36 from $31 and keeps a Buy rating on the shares. The firm upped the price target after analyzing the impact of Stelara in 2026.
Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on OPCH:
- Option Care Health: Strong Growth Prospects and Strategic Initiatives Drive Buy Rating
- Option Care Health management to meet with Truist
- Option Care Health price target lowered to $27 from $30 at TD Cowen
- Option Care Health’s Earnings Call Highlights Growth and Challenges
- Option Care Health price target lowered to $36 from $38 at Citizens JMP